退-

Yanxian Zhang1, Yijing Tang2, Lijin Wang3

  • 1Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine Stanford University, Stanford, CA 94305, USA.

Research (Washington, D.C.)
|February 26, 2026
PubMed
概括

抗微生物 (AMP) 正在成为粉样蛋白聚合的关键调节剂,影响蛋白质错折和炎症. 工程化AMP显示出对粉样蛋白疾病的双重作用疗法的潜力.